| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.894 | 15.321 | 15.031 | 15.510 | 13.324 | 21.756 | 64.209 | 56.583 | 46.250 | 0 |
| Total Income - EUR | 19.050 | 15.332 | 26.248 | 15.517 | 40.064 | 22.159 | 64.212 | 56.585 | 48.711 | 25.330 |
| Total Expenses - EUR | 17.538 | 15.001 | 25.749 | 14.299 | 14.303 | 15.058 | 27.604 | 23.623 | 37.380 | 1.077 |
| Gross Profit/Loss - EUR | 1.512 | 331 | 499 | 1.218 | 25.761 | 7.102 | 36.608 | 32.962 | 11.331 | 24.253 |
| Net Profit/Loss - EUR | 945 | 211 | 239 | 1.063 | 25.627 | 6.884 | 35.965 | 32.396 | 10.869 | 24.253 |
| Employees | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 0 |
Check the financial reports for the company - Vetermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 876 | 370 | 706 | 422 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 19.007 | 16.320 | 10.329 | 13.650 | 8.624 | 23.180 | 50.778 | 15.069 | 14.382 | 37.783 |
| Inventories | 10.960 | 11.784 | 2.654 | 5.130 | 4.312 | 5.828 | 986 | 1.724 | 9 | 9 |
| Receivables | 148 | 99 | 1.644 | 352 | 621 | 10.791 | 15.872 | 6.954 | 7.822 | 33.295 |
| Cash | 7.899 | 4.436 | 6.031 | 8.168 | 3.692 | 6.561 | 33.920 | 6.392 | 6.552 | 4.480 |
| Shareholders Funds | -24.551 | -24.090 | -23.443 | -21.949 | 4.217 | 11.021 | 40.011 | 72.531 | 11.089 | 35.280 |
| Social Capital | 45 | 45 | 44 | 43 | 156 | 153 | 150 | 150 | 150 | 149 |
| Debts | 44.434 | 40.780 | 34.477 | 36.021 | 4.407 | 12.159 | 11.067 | 3.372 | 3.293 | 2.503 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Vetermed Srl